ArticleBioengineering & translational medicine2026

PEGylated thymosin β4 is a thiol-site-specific prodrug treating myocardial infarction in vivo.

Haisheng Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.